Improve Research Reproducibility A Bio-protocol resource
- Home
- Protocols
-
Concise Method
Evaluation of responses and toxicity
Ask a
question
Favorite
We evaluated the overall survival (OS) and progression-free survival (PFS). OS was measured as the period from the initiation of immunotherapy to death. PFS was measured as the period from the first administration of immunotherapy to documented disease progression or death from any cause. Treatment response was assessed using the Response Evaluation Criteria in Solid Tumors (RECIST) version 1.1. The censored date was Aug 17, 2020.
Copyright and License information: ©2021 Translational Lung Cancer Research. All rights reserved.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.
Post a Question0 Q&A
